CY1121147T1 - Νεες συντηγμενες ενωσεις ιμιδαζοβενζοθειαζολιου - Google Patents

Νεες συντηγμενες ενωσεις ιμιδαζοβενζοθειαζολιου

Info

Publication number
CY1121147T1
CY1121147T1 CY20191100076T CY191100076T CY1121147T1 CY 1121147 T1 CY1121147 T1 CY 1121147T1 CY 20191100076 T CY20191100076 T CY 20191100076T CY 191100076 T CY191100076 T CY 191100076T CY 1121147 T1 CY1121147 T1 CY 1121147T1
Authority
CY
Cyprus
Prior art keywords
compounds
imidazovenzothiazolium
functioned
new
medicament
Prior art date
Application number
CY20191100076T
Other languages
English (en)
Inventor
Pundlik SHINDE
Sanjay Srivastava
Davindar TULI
Deepak Rai
Prashant GJ
Shailesh Deshpande
Rameshchandra GUPTA
Vijay Chauthaiwale
Chaitanya Dutt
Original Assignee
Torrent Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Limited filed Critical Torrent Pharmaceuticals Limited
Publication of CY1121147T1 publication Critical patent/CY1121147T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Η παρούσα εφεύρεση αναφέρεται σε νέα συντηγμένα παράγωγα ιμιδαζοβενζοθειαζολίου, τα φαρμακευτικά αποδεκτά άλατα αυτών και τα ισομερή τους, τα στερεοϊσομερή, τα ατροπισομερή, τα διαμορφομερή, τα ταυτομερή, τα πολύμορφα, τα ένυδρα άλατα, τα διαλύματα και το Ν-οξείδιο. Η παρούσα εφεύρεση επίσης περιλαμβάνει τις φαρμακευτικά αποδεκτές συνθέσεις των αναφερθεισών ενώσεων και μια μέθοδο για την παρασκευή νέων ενώσεων. Η εφεύρεση αναφέρεται περαιτέρω στη χρήση των ανωτέρω αναφερθεισών ενώσεων για την παρασκευή ενός φαρμάκου προς χρήση ως φαρμακευτικά προϊόντα.
CY20191100076T 2014-03-27 2019-01-21 Νεες συντηγμενες ενωσεις ιμιδαζοβενζοθειαζολιου CY1121147T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1089MU2014 2014-03-27
PCT/IB2015/052124 WO2015145336A1 (en) 2014-03-27 2015-03-24 Novel fused imidazobenzothiazole compounds

Publications (1)

Publication Number Publication Date
CY1121147T1 true CY1121147T1 (el) 2020-05-29

Family

ID=54194050

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191100076T CY1121147T1 (el) 2014-03-27 2019-01-21 Νεες συντηγμενες ενωσεις ιμιδαζοβενζοθειαζολιου

Country Status (29)

Country Link
US (2) US9908898B2 (el)
EP (1) EP3122755B1 (el)
JP (1) JP6480949B2 (el)
KR (1) KR102339610B1 (el)
CN (1) CN106414458B (el)
AR (1) AR099867A1 (el)
AU (1) AU2015237840B2 (el)
CA (1) CA2943098C (el)
CY (1) CY1121147T1 (el)
DK (1) DK3122755T3 (el)
EA (1) EA029745B9 (el)
ES (1) ES2707099T3 (el)
HR (1) HRP20190121T1 (el)
HU (1) HUE042493T2 (el)
IL (1) IL247955B (el)
LT (1) LT3122755T (el)
MX (1) MX368985B (el)
MY (1) MY193041A (el)
PH (1) PH12016501903A1 (el)
PL (1) PL3122755T3 (el)
PT (1) PT3122755T (el)
RS (1) RS58324B1 (el)
SG (1) SG11201607793RA (el)
SI (1) SI3122755T1 (el)
TR (1) TR201900735T4 (el)
TW (1) TWI648282B (el)
UA (1) UA121469C2 (el)
WO (1) WO2015145336A1 (el)
ZA (1) ZA201606598B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105073728A (zh) 2013-03-15 2015-11-18 全球血液疗法股份有限公司 化合物及其用于调节血红蛋白的用途
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
TWI648282B (zh) * 2014-03-27 2019-01-21 印度商托仁特生技有限公司 新熔合咪唑苯并噻唑化合物
DE102016209204A1 (de) 2016-05-27 2017-11-30 Robert Bosch Gmbh Vorrichtung zur Regelung mindestens eines Fluidstroms in einem Fahrzeug
KR102630959B1 (ko) * 2016-10-31 2024-01-29 엘지디스플레이 주식회사 유기 화합물과 이를 이용한 발광다이오드 및 유기발광다이오드 표시장치
CN106727538A (zh) * 2017-02-20 2017-05-31 潘连香 一种治疗2型糖尿病的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724566D0 (en) 1987-10-20 1987-11-25 Roussel Lab Ltd Chemical compounds
GB8908845D0 (en) 1989-04-19 1989-06-07 Roussel Lab Ltd Chemical compounds
WO1995029922A1 (en) 1994-04-29 1995-11-09 Pharmacia & Upjohn Company Methanol derivatives for treatment of retroviral infections especially hiv infections
WO2002014321A1 (en) 2000-08-11 2002-02-21 The Regents Of The University Of California Use of stat-6 inhibitors as therapeutic agents
US7601846B2 (en) 2001-06-26 2009-10-13 The Regents Of The University Of California Compounds having activity as inhibitors of apoptosis
MXPA05005474A (es) * 2002-11-25 2005-07-25 Pharmacia Corp Acidos y amidas heteroarilsulfonilmetil hidroxamicos y su uso como inhibidores de proteasas.
GB0320244D0 (en) * 2003-05-06 2003-10-01 Aventis Pharma Inc Pyrazoles as inhibitors of tumour necrosis factor
EP1984363A1 (en) * 2006-02-09 2008-10-29 Pfizer Limited Triazolopyridine compounds
TWI648282B (zh) * 2014-03-27 2019-01-21 印度商托仁特生技有限公司 新熔合咪唑苯并噻唑化合物

Also Published As

Publication number Publication date
KR102339610B1 (ko) 2021-12-14
PL3122755T3 (pl) 2019-05-31
EA201691920A1 (ru) 2017-01-30
EA029745B1 (ru) 2018-05-31
ES2707099T3 (es) 2019-04-02
EP3122755A1 (en) 2017-02-01
US20170107233A1 (en) 2017-04-20
AU2015237840B2 (en) 2019-06-20
MY193041A (en) 2022-09-23
HRP20190121T1 (hr) 2019-03-08
EP3122755B1 (en) 2018-11-07
SG11201607793RA (en) 2016-10-28
MX2016012535A (es) 2017-05-04
SI3122755T1 (sl) 2019-02-28
MX368985B (es) 2019-10-23
CA2943098A1 (en) 2015-10-01
HUE042493T2 (hu) 2019-07-29
PH12016501903B1 (en) 2017-01-09
AR099867A1 (es) 2016-08-24
WO2015145336A1 (en) 2015-10-01
LT3122755T (lt) 2019-02-11
NZ724342A (en) 2021-02-26
RS58324B1 (sr) 2019-03-29
TW201613941A (en) 2016-04-16
IL247955A0 (en) 2016-11-30
AU2015237840A1 (en) 2016-09-29
PT3122755T (pt) 2019-01-30
CN106414458B (zh) 2019-10-29
CN106414458A (zh) 2017-02-15
US9908898B2 (en) 2018-03-06
JP6480949B2 (ja) 2019-03-13
DK3122755T3 (en) 2019-02-18
CA2943098C (en) 2022-07-05
TWI648282B (zh) 2019-01-21
EA029745B9 (ru) 2018-08-31
US10227361B2 (en) 2019-03-12
KR20160129089A (ko) 2016-11-08
ZA201606598B (en) 2017-11-29
PH12016501903A1 (en) 2017-01-09
JP2017513825A (ja) 2017-06-01
IL247955B (en) 2021-02-28
UA121469C2 (uk) 2020-06-10
US20180127437A1 (en) 2018-05-10
TR201900735T4 (tr) 2019-02-21

Similar Documents

Publication Publication Date Title
CY1121147T1 (el) Νεες συντηγμενες ενωσεις ιμιδαζοβενζοθειαζολιου
PH12018500591A1 (en) Heterocyclic compounds and uses thereof
EA201791256A1 (ru) Производные хиназолина, применяемые для лечения вич
EA201691302A1 (ru) Новые гетероциклические соединения
CO2018000589A2 (es) Oxiesteroles y composiciones farmacéuticas que los contienen
EA201790389A1 (ru) Пирролопиримидиновые соединения, используемые в качестве агониста tlr7
EA201791304A1 (ru) Производные изохинолина для лечения вич
UY35663A (es) Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos
TW201613872A (en) IRAK4 inhibiting agents
CU20160192A7 (es) Derivados de indano e indolina útiles como activadores de la guanilato ciclasa soluble
EA201790395A1 (ru) Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы
TW201613567A (en) Use of gabaa receptor reinforcing agent in preparation of sedative and anesthetic medicament
DOP2017000034A (es) Compuestos de imidazopiridazina
CY1124251T1 (el) Παραγωγα καρβοξαμιδιου
EA201791600A1 (ru) Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора
UY36123A (es) Derivados de carboxamida
MA40250A (fr) Dérivés de quinolizinone utilisés comme inhibiteurs de pi3k
CY1119710T1 (el) Συντηγμενες θειαζολο- και οξαζολο-πυριμιδινονες
MX2017009292A (es) Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3.
EA201792234A1 (ru) Новые соединения пиридиния
ECSP19013196A (es) Derivado de triazolopirazinona útil como un inhibidor de pde1 humana
PH12018502246A1 (en) Substituted fused pyrimidinone compounds
EA201791396A1 (ru) ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ
EA201791397A1 (ru) СВЯЗАННЫЕ С ГЕТЕРОЦИКЛИЛАМИ ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ
MX2018015990A (es) Compuestos terapeuticos.